278 related articles for article (PubMed ID: 25428220)
21. STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment.
Benoit A; Abraham MJ; Li S; Kim J; Estrada-Tejedor R; Bakadlag R; Subramaniam N; Makhani K; Guilbert C; Tu R; Salaciak M; Klein KO; Coyle KM; Hilton LK; Santiago R; Dmitrienko S; Assouline S; Morin RD; Del Rincon SV; Johnson NA; Mann KK
Int J Hematol; 2024 Mar; 119(3):275-290. PubMed ID: 38285120
[TBL] [Abstract][Full Text] [Related]
22. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
23. Counter-regulation mechanism of IL-4 and IFN-α signal transduction through cytosolic retention of the pY-STAT6:pY-STAT2:p48 complex.
Kim SH; Lee CE
Eur J Immunol; 2011 Feb; 41(2):461-72. PubMed ID: 21268015
[TBL] [Abstract][Full Text] [Related]
24. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas.
Malpeli G; Barbi S; Moore PS; Scardoni M; Chilosi M; Scarpa A; Menestrina F
Haematologica; 2004 Sep; 89(9):1091-9. PubMed ID: 15377470
[TBL] [Abstract][Full Text] [Related]
25. Recurrent somatic mutations affecting B-cell receptor signaling pathway genes in follicular lymphoma.
Krysiak K; Gomez F; White BS; Matlock M; Miller CA; Trani L; Fronick CC; Fulton RS; Kreisel F; Cashen AF; Carson KR; Berrien-Elliott MM; Bartlett NL; Griffith M; Griffith OL; Fehniger TA
Blood; 2017 Jan; 129(4):473-483. PubMed ID: 28064239
[TBL] [Abstract][Full Text] [Related]
26. E2F1/SP3/STAT6 axis is required for IL-4-induced epithelial-mesenchymal transition of colorectal cancer cells.
Chen J; Gong C; Mao H; Li Z; Fang Z; Chen Q; Lin M; Jiang X; Hu Y; Wang W; Zhang X; Chen X; Li H
Int J Oncol; 2018 Aug; 53(2):567-578. PubMed ID: 29901191
[TBL] [Abstract][Full Text] [Related]
27. Multiplex Droplet Digital PCR Quantification of Recurrent Somatic Mutations in Diffuse Large B-Cell and Follicular Lymphoma.
Alcaide M; Yu S; Bushell K; Fornika D; Nielsen JS; Nelson BH; Mann KK; Assouline S; Johnson NA; Morin RD
Clin Chem; 2016 Sep; 62(9):1238-47. PubMed ID: 27440511
[TBL] [Abstract][Full Text] [Related]
28. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease.
Nann D; Ramis-Zaldivar JE; Müller I; Gonzalez-Farre B; Schmidt J; Egan C; Salmeron-Villalobos J; Clot G; Mattern S; Otto F; Mankel B; Colomer D; Balagué O; Szablewski V; Lome-Maldonado C; Leoncini L; Dojcinov S; Chott A; Copie-Bergman C; Bonzheim I; Fend F; Jaffe ES; Campo E; Salaverria I; Quintanilla-Martinez L
Blood Adv; 2020 Nov; 4(22):5652-5665. PubMed ID: 33211828
[TBL] [Abstract][Full Text] [Related]
29. The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion.
Zamò A; Pischimarov J; Horn H; Ott G; Rosenwald A; Leich E
Br J Haematol; 2018 Feb; 180(3):391-394. PubMed ID: 29193015
[TBL] [Abstract][Full Text] [Related]
30. Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells.
Yuan Q; Li PD; Li BH; Yang XZ; Xu SB; Liu XH; Zhou FX; Zhang WJ
J Cancer Res Clin Oncol; 2009 Jan; 135(1):131-40. PubMed ID: 18536936
[TBL] [Abstract][Full Text] [Related]
31. Pervasive mutations of JAK-STAT pathway genes in classical Hodgkin lymphoma.
Tiacci E; Ladewig E; Schiavoni G; Penson A; Fortini E; Pettirossi V; Wang Y; Rosseto A; Venanzi A; Vlasevska S; Pacini R; Piattoni S; Tabarrini A; Pucciarini A; Bigerna B; Santi A; Gianni AM; Viviani S; Cabras A; Ascani S; Crescenzi B; Mecucci C; Pasqualucci L; Rabadan R; Falini B
Blood; 2018 May; 131(22):2454-2465. PubMed ID: 29650799
[TBL] [Abstract][Full Text] [Related]
32. Unusual Variants of Follicular Lymphoma: Case-based Review.
Chapman JR; Alvarez JP; White K; Sanchez S; Khanlari M; Algashaamy K; Cassidy D; Peng JH; Fan YS; Alencar A; Alderuccio JP; Lossos IS; Vega F
Am J Surg Pathol; 2020 Mar; 44(3):329-339. PubMed ID: 31688142
[TBL] [Abstract][Full Text] [Related]
33. LPS Exposure in Early Life Protects Against Mucus Hypersecretion in Ovalbumin-Induced Asthma by Down-Regulation of the IL-13 and JAK-STAT6 Pathways.
Ding F; Liu B; Zou W; Tian D; Li Q; Dai J; Luo Z; Fu Z
Cell Physiol Biochem; 2018; 46(3):1263-1274. PubMed ID: 29680833
[TBL] [Abstract][Full Text] [Related]
34. STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line.
Baus D; Nonnenmacher F; Jankowski S; Döring C; Bräutigam C; Frank M; Hansmann ML; Pfitzner E
Leukemia; 2009 Oct; 23(10):1885-93. PubMed ID: 19440213
[TBL] [Abstract][Full Text] [Related]
35. STAT6 and JAK1 are essential for IL-4-mediated suppression of prostaglandin production in human follicular dendritic cells: opposing roles of phosphorylated and unphosphorylated STAT6.
Cho W; Jeoung DI; Kim YM; Choe J
Int Immunopharmacol; 2012 Apr; 12(4):635-42. PubMed ID: 22406175
[TBL] [Abstract][Full Text] [Related]
36. Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
Morin RD; Assouline S; Alcaide M; Mohajeri A; Johnston RL; Chong L; Grewal J; Yu S; Fornika D; Bushell K; Nielsen TH; Petrogiannis-Haliotis T; Crump M; Tosikyan A; Grande BM; MacDonald D; Rousseau C; Bayat M; Sesques P; Froment R; Albuquerque M; Monczak Y; Oros KK; Greenwood C; Riazalhosseini Y; Arseneault M; Camlioglu E; Constantin A; Pan-Hammarstrom Q; Peng R; Mann KK; Johnson NA
Clin Cancer Res; 2016 May; 22(9):2290-300. PubMed ID: 26647218
[TBL] [Abstract][Full Text] [Related]
37. Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6.
Mottok A; Renné C; Willenbrock K; Hansmann ML; Bräuninger A
Blood; 2007 Nov; 110(9):3387-90. PubMed ID: 17652621
[TBL] [Abstract][Full Text] [Related]
38. IL-4-mediated transcriptional regulation of human CYP2E1 by two independent signaling pathways.
Wang J; Hu Y; Nekvindova J; Ingelman-Sundberg M; Neve EP
Biochem Pharmacol; 2010 Nov; 80(10):1592-600. PubMed ID: 20723539
[TBL] [Abstract][Full Text] [Related]
39. Coactivator P100 protein enhances STAT6-dependent transcriptional activation but has no effect on STAT1-mediated gene transcription.
Wang X; Liu X; Fang J; Lu Y; He J; Yao X; Yao Z; Yang J
Anat Rec (Hoboken); 2010 Jun; 293(6):1010-6. PubMed ID: 20225206
[TBL] [Abstract][Full Text] [Related]
40. The fungal metabolite cyclonerodiol inhibits IL-4/IL-13 induced Stat6-signaling through blocking the association of Stat6 with p38, ERK1/2 and p300.
Rudolph AK; Walter T; Erkel G
Int Immunopharmacol; 2018 Dec; 65():392-401. PubMed ID: 30380514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
